Press Releases
Press Release
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™
April 12, 2021
Press Release
Cardiol Therapeutics Announces Filing of 2020 Year-end Financial Statements and MD&A
April 01, 2021
Press Release
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
March 30, 2021
Press Release
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options
March 02, 2021
Press Release
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
January 21, 2021
Press Release
Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences
January 07, 2021
Press Release
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
December 22, 2020
Press Release
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19
December 15, 2020
Press Release
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
October 20, 2020
